Structural Bioinformatics and QSAR Analysis Applied to the Acetylcholinesterase and Bispyridinium Aldoximes

References

• Ashani, Y., Radic, Z., Tsigelny, D. C., Vellmom, D. C., Pickering, N. A., Quinn, D. M., Doctor, B. P., and Taylor, P. (1995). Amino acid residues controlling reactivation of organophosphonyl conjugates of acetylcholinesterase by mono- and bisquaternary oximes. J. Biol. Chem., 270, 6370- 6380.
   PubMed Web of Science ®Google Scholar
• Grosfeld, H., Barak, D., Ordentlich, A., Velan, B., and Shafferman, A. (1996). Interactions of oxime reactivators with diethylphosphoryl adducts of human acetylcholinesterase and its mutant derivatives. Mol. Pharmacol., 50, 639–649.
   PubMed Web of Science ®Google Scholar
• Wong, L., Radic, Z., Brüggemann, R. J. M., Hosea, N., Berman, H. A., and Taylor, P. (2000). Mechanism of oxime reactivation of acetylcholinesterase analyzed by chirality and mutagenesis. Biochemistry, 39, 5750–5757.
   PubMed Web of Science ®Google Scholar
• Luo, C., Leader, H., Radic, Z., Maxwell, D. M., Taylor, P., Doctor, B. P., and Saxena, A. (2003). Two possible orientations of the HI-6 molecule in the reactivation of organophosphate-inhibited acetylcholinesterase. Biochem. Pharmacology, 66, 387–392.
   PubMed Web of Science ®Google Scholar
• Hammond, P. I., Kern, C., Hong, F., Kollmeyer, T. M., Pang, Y.-P., and Brimijoin, S. (2003). Cholinesterase reactivation in vivo with a novel bis-oxime optimized by computer-aided design. J. Pharmacol. Exp. Ther., 307, 190–196.
   PubMed Web of Science ®Google Scholar
• Pang, Y.-P., Kollmeyer, T. M., Hong, F., Lee, J.-C., Hammond, P. I., Haugabouk, S. P., and Brimijoin, S. (2003). Rational design of alkylene-linked bis-pyridiniumoximes as improved acetylcholinesterase reactivators. Chem. Biol., 10, 491- 502.
   PubMed Web of Science ®Google Scholar
• Mager, P. P. (1981). Quantitative structure-reactivity and structure-toxicity relationships of reactivators of phosphylated acetylcholinesterase. Pharmazie, 36, 450–451.
   PubMed Web of Science ®Google Scholar
• Mager, P. P. (1982). Quantitative structure-activity relationships of reactivators of phosphylated acetylcholinesterase. Pharmazie, 37, 800–801
   PubMed Web of Science ®Google Scholar
• Mager, P. P., and Das Gupta, S. (1982). Quantitative structure-activity relationships of reactivators of phosphylated acetylcholinesterase. Pharmazie, 37, 607–608.
   PubMed Web of Science ®Google Scholar
• Mager, P. P., and Seese, A. (1982). Organophosphorus pesticides and mammalicides: A mathematical study on chemical structure and biological activity applied to parameters of inhibition of myoneuronal junctions, axon demyelination, and reactivation of poisoned acetylcholinesterase. Zool. Jahrb. Anat., 107,46-70.
   Google Scholar
• Mager, P. P. (1994). The oxime problem can be solved by molecular simulation, Sci. Conf. Chem. Biol. Defense Res., Comput. Chem. Sect., 15-18 Nov. 1994, U.S. Army Edgewood Area Conf. Center: Aberdeen Proving Ground, MD, p. 166.
   Google Scholar
• Dayhoff, M. O., Barker, W. C., and Hunt, L. T. (1983). Establishing homology in protein sequence. Meth. Enzymol., 91, 524–545.
   PubMed Web of Science ®Google Scholar
• Corpet, F. (1988). Multiple alignment analysis with hierarchical clustering. Nucl. Acids Res., 16, 10881–10890.
   PubMed Web of Science ®Google Scholar
• Thompson, J. D., Higgins, D. G., and Gibson, T. J. (1994). ClustalW: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice. Nucl. Acids Res., 22, 4673–4680.
   PubMed Web of Science ®Google Scholar
• Bairoch, A. (1996). The PROSITE database. Nucleic Acid Res., 24, 189–196.
   PubMed Web of Science ®Google Scholar
• Corpet, F., Gouzy, J., and Kahn, D. (1999). Recent improvements of the ProDom database of protein domain families. Nucleic Acids Res., 27, 263–267.
   PubMed Web of Science ®Google Scholar
• Attwood, T. K., Croning, M. D. R., Flower, D. R., Lewis, A. P., Mabey, J. E., Scordis, P., Selley, J. N., and Right, W. (2000). PRINT-S: The database formerly known as PRINTS. Nucl. Acids Res., 28, 225–227.
   PubMed Web of Science ®Google Scholar
• Attwood, T. K., Blythe, M., Flower, D. R., Gaulton, A., Mabey, J. E., Maudling, N., McGregor, L., Mitchell, A., Moulton, G., Paine, K., and Scordis, P. (2002). PRINTS and PRINT-S shed light on protein ancestry. Nucl. Acids Res., 30, 239–241.
   PubMed Web of Science ®Google Scholar
• Bateman, A., Birney, E., Cerruti, L., Durbin, R., Etwiller, L., Eddy, S. R., Griffiths-Jones, S., Howe, K. L., Marshall, M., and Sonnhammer, E. L. (2002). The PFAM protein families database. Nucl. Acids Res., 30, 276–280.
   PubMed Web of Science ®Google Scholar
• Falquet, L., Pagni, M., Bucher, P., Hulo, N., Sigrist, C. J., Hofmann, K., and Bairoch, A. (2002). The PROSITE database, its status in 2002. Nucl. Acids Res., 30, 235–238. MODELLING OF AChE AND ALDOXIMES 149
   Google Scholar
• Chen, C. P., Kernytsky, A., and Rost, B. (2002). Transmembrane helix predictions revisited. Protein Sci., 11, 2774–2791.
   PubMed Web of Science ®Google Scholar
• Ryde, U., Olsen, L., and Nilsson, K. (2002). Quantum chemical geometry optimizations in proteins using crystallographic raw data. J. Comput. Chem., 23, 1058–1070.
   PubMed Web of Science ®Google Scholar
• Taylor, R. (2002). Life-science applications of the cambridge structural database. Acta Cryst., D58, 879–888.
   Web of Science ®Google Scholar
• Mager, P. P. (1984). Multidimensional Pharmacochemistry, Academic Press, New York, pp. 51, 355, 356, 365–367.
   Google Scholar
• Glick, M., Grant, G. H., and Richards, W. G. (2002). Docking of flexible molecules using multiscale ligand representations. J. Med. Chem., 45, 4639–4646.
   PubMed Web of Science ®Google Scholar
• Hansch, C., and Leo, A. (1979). Substituent Constants for Correlation Analysis in Chemistry and Biology, Wiley, New York.
   Google Scholar
• Hansch, C., and Leo, A. (1995). Exploring QSAR: Fundamentals and Applications in Chemistry and Biology, Am. Chem. Soc., Washington, DC.
   Google Scholar
• Fujita, T. (1990). The extrathermodynamic approach to drug design. Compr. Med. Chem., 4, 497–560.
   Google Scholar
• Walters, D. E., and Hopfinger, A. J. (1984). Application of molecular shape analysis in QSAR, In QSAR in Design of Bioactive Compounds, edited by M. Kuchar, Proc. 1st Telesymp. Med. Chem. 1984, J. R. Prous Sci. Publ., Barcelona, pp. 279–286.
   Google Scholar
• Remko, M., Scheiner, S., and Van Duijnen, P. T. (1992). Ab initio investigations of interactions between models of local anesthetics and polar groups of membranes. In QSAR in Design of Bioactive Compounds, edited by M. Kuchar, Proc. 2nd Telesymp. Med. Chem. 1992, J. R. Prous Sci. Publ., Barcelona, pp. 83–95.
   Google Scholar
• Free, S. M., and Wilson, J. W. (1964). A mathematical contribution to structure-activity studies. J. Med. Chem., 7, 395–399.
   PubMed Web of Science ®Google Scholar
• Hall, L. H., and Kier, L. B. (1976). Molecular Connectivity in Chemistry and Drug Research. New York: Academic Press.
   Google Scholar
• Verloop, A., Hoogenstraaten, W., and Tipker, J. (1976). Development and application of new steric substituent parameters in drug design, in: Ariens, E. J. (Ed.). Drug Design. New York: Academic Press, Vol. 7, pp. 165–207.
   Google Scholar
• Dixon, S. L., and Jurs, P. C. (1993). Estimation of pKa for organic oxyacids using calculated atomic charges. J. Comput. Chem., 14, 1460–1467.
   Web of Science ®Google Scholar
• Meylan, W. M., and Howard, P. H. (1995). Atom/fragment contribution method for estimating octanol-water partition coefficients. J. Pharmaceut. Sci., 84,83-92.
   Web of Science ®Google Scholar
• Oldiges. K., and Schoene, K. (1970). Pyridinium and imidazolium salts as antidotes for soman and paraoxon poisoning in mice. Arch. Toxicol., 26, 293–305.
   Google Scholar
• Schoene, K., and Oldiges, K. (1973). Efficacy of pyridinium salts in tabun and sarin poisoning in vivo and in vitro. Arch. Int. Pharmacodyn. Ther., 204, 110–123.
   Google Scholar
• Schoene, K. (1980). Pyridinium salts as organophosphate antagonists, Monogr. Neural. Sci., 7,85-98.
   Google Scholar
• Mager, P. P. (1988). Multivariate Chemometrics in QSAR: A Dialogue. New York: Wiley.
   Google Scholar
• Mager, P. P. (1991). Design Statistics in Pharmacochemistry. New York: John Wiley.
   Google Scholar
• Schneider, G. (2000). Neural networks are useful tools for drug design. Neural Netw., 13,15-60.
   Google Scholar
• Mager, P. P., and Reinhardt, R. (2000). Comparison of neural network and regression models in molecular simulation of relationships between chemical structure and biological activity. Mol. Simul., 28, 287–294.
   Web of Science ®Google Scholar
• Radic, Z., Gibney, G., Kawamoto, S., MacPhee-Quigley, K., Bongiorno, C., and Taylor, P. (1993). Three distinct domains in the cholinesterase molecule confer selectivity for acetyland butyrylcholinesterase inhibitors. Biochemistry, 32, 12074- 12084.
   Google Scholar
• Radic, Z., Pickering, N. A., Vellom, D. C., Camp, S., and Taylor, P. (1993). Expression of recombinant acetylcholinesterase in a baculovirus system: Kinetic properties of glutamate 199 mutants. Biochemistry, 31, 9760–9767.
   Web of Science ®Google Scholar
• Harel, M., Sussman, J. L., Krejci, E., Bon, S., Chanal, P., Massoulie, J., and Silman, I. (1992). Conversion of acetylcholinesterase to butylcholinesterase: modeling and mutagenesis. Proc. Natl. Acad. Sci. USA, 89, 10827–10831.
   PubMed Web of Science ®Google Scholar
• Ordentlich, A., Barak, D., Kronman, C., Flashner, Y., Leitner, M., Segall, Y., Ariel, N., Cohen, S., Velan, B., and Shafferman, A. (1993). Dissection of the human acetylcholinesterase active center determinants of substrate specificity. Identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocket. J. Biol. Chem., 268, 17083–17095.
   PubMed Web of Science ®Google Scholar
• Masson, P., Froment, M.-T., Bartels, C., and Lockridge, O. (1997). Importance of aspartate-70 in organophasphate inhibition, oxime re-activation and aging of human acetylcholinesterase. Biochem. J., 325,53-61.
   Web of Science ®Google Scholar
• Massoulie, J., Pezzementi, L., Bon, S., Krejci, E., and Vallette, F.-M. (1993). Molecular and cellular biology of cholinesterases. Prog. Neurobiol., 41,31-91.
   Web of Science ®Google Scholar
• Taylor, P., and Radic, Z. (1994). The cholinesterases: From genes to proteins. Annu. Rev. Pharmacol. Toxicol., 34, 281- 320.
   PubMed Web of Science ®Google Scholar
• Sussman, J. L., Harel, M., Frolow, F., Oefner, C., Goldman, A., Toker, L., and Silman, I. (1991). Atomic structure of acetylcholinesterase from Torpedo california: A prototypic acetylcholine-binding protein. Science, 253, 872–879.
   PubMed Web of Science ®Google Scholar
• Bernard, P. P., Kireev, D. B., Pintore, M., Chretien, J. R., Fortier, P.-L., and Froment, D. (2000). A CoMFA study of enantiomeric organophosphorus inhibitors of acetylcholinesterase. J. Mol. Model., 6, 618–629.
   Web of Science ®Google Scholar
• Kua, J., Zhang, Y., and McCammon, J. A. (2002). Studying enzyme binding specificity in acetylcholinesterase using a combined molecular dynamics and multiple docking approach. J. Am. Chem. Soc., 124, 8260–8267.
   PubMed Web of Science ®Google Scholar
• Harel, M., Quinn, D. M., Nair, H. K., Silman, I., and Sussman, J. L. (1996). The X-ray structure of a transition state analog complex reveals the molecular origins on the catalytic power and substrate specificity of acetylcholinesterase. J. Am. Chem. Soc., 118, 2340–2346.
   Web of Science ®Google Scholar
• Shi, J., Tai, K., McCammon, A., Taylor, P., and Johnson, D. A. (2003). Nanosecond dynamics of the mouse acetylcholinesterase Cys69-Cys95 omega loop. J. Biol. Chem., 278, 30905–30911.
   PubMed Web of Science ®Google Scholar
• Chen, J. W., Luo, Y. L., Hwang, M. J., Peng, P. C., and Ling, K. H. (1999). Territrem B, a tremorgenic mycotoxin that inhibits acetylcholinesterase with a noncovalent yet irreversible binding mechanism. J. Biol. Chem., 274, 34916–34923.
   PubMed Web of Science ®Google Scholar
• Shen, T., Tai, K., Henchman, R. H., and McCammon, J. A. (2002). Molecular dynamics of acetylcholinesterase. Acc. Chem. Res., 35, 332–340.
   PubMed Web of Science ®Google Scholar
• Davies, H., Richter, R., Keifer, M., Broomfield, C., Sowalla, J., and Furlong, C. (1996). The effect of human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat. Genet., 14, 334–336.
   PubMed Web of Science ®Google Scholar
• Boström, J. (2001). Reproducing the conformations of protein-bound ligands: A critical evaluation of several popular conformational searching tools. J. Comput.-Aided Mol. Des., 15, 1137–1152.
   PubMed Web of Science ®Google Scholar
• Boström, J., Greenwood, J. R., and Gottfries, J. (2003). Assessing the performance of OMEGA with respect to retrieving bioactive conformations. J. Mol. Graphics Model., 21, 449- 462.
   PubMed Web of Science ®Google Scholar
• Clark, R. D., Strizhev, A., Leonard, J. M., Blake, J. F., and Matthew, J. B. (2002). Consensus scoring for ligand/protein interactions. J. Mol. Graphics Model., 20, 281–295.
   PubMed Web of Science ®Google Scholar
• Glick, M., Grant, G. H., and Richards, W. G. (2002). Docking of flexible molecules using multiscale ligand representations. J. Med. Chem., 45, 4639–4646.
   PubMed Web of Science ®Google Scholar
• Palm, V. A. (1991). Grundlagen der quantitativen Theorie organischer Reaktionen. Berlin: Akademie-Verlag, pp. 220- 221.
   Google Scholar
• Schwetlick, K. (1991). Kinetische Methoden zur Untersuchung von Reaktionsmechanismen, Berlin: Akademie-Verlag, p. 177.
   Google Scholar
• Mager, P. P. (1997). How design statistics concepts can improve experimentation in medicinal chemistry. Med. Res. Rev., 17, 453–475.
   PubMed Web of Science ®Google Scholar
• De Jong, L. P., Verhagen, M. A., Langenberg, J. P., Hagedorn, I., and Loffler, M. (1989). The bispyridinium-dioxime HLo-7. A potent reactivator for acetylcholinesterase inhibited by stereoisomers of tabun and soman. Biochem. Pharmacol., 38, 633–640.
   PubMed Web of Science ®Google Scholar
• Worek, F., Kirchner, T., Bäcker, M., and Szinics, L. (1996). Reactivation by various aldoximes of human erythrocyte acetylcholinesterase inhibited by different organophosphorus compounds. Arch. Toxicol., 70, 497–503.
   PubMed Web of Science ®Google Scholar
• Worek, F., Kirchner, T., and Szinics, L. (1995). Effect of atropine, HLö 7, and HI 6 on respiratory and circulatory function in sarin poisoned guinea-pigs. Toxicology, 95, 123–133.
   PubMed Web of Science ®Google Scholar
• Worek, F., Widmann, R., Knopff, O., and Szinics, L. (1998). Reactivating potency of obidoxime, pralidoxime, HI 6 and HLo 7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds. Arch. Toxicol., 72, 237- 243.
   PubMed Web of Science ®Google Scholar
• Worek, F., Reiter, G., Eyer, P., and Szinics, L. (2002). Reactivation kinetics of acetylcholinesterase from different species inhibited by highly toxic organophosphates. Arch. Toxicol., 76, 523–529.
   PubMed Web of Science ®Google Scholar
• Polyzou, A., Froment, M.-T., Masson, P., and Belzunces, L. P. (1998). Absence of a protective effect of the oxime 2-PAM toward paraoxon-poisoned honey bees: Acetylcholinesterase reactivation not a fault. Toxicol. Appl. Pharmacol., 152, 184–192.
   PubMed Web of Science ®Google Scholar